RIGEL

Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer... In addition, Rigel has an extensive portfolio of investigational agents being developed with our other partners. These products are focused on the inhibition of select signaling pathways, including Axl tyrosine kinase (AXL) and murine double minute 2 (MDM2). Through strategic partnerships and collaborations, we are able to take advantage of additional experience and resources, while benefiting from the potential success of these future products, both through milestone payments and royalties.

Also known as: Rigel Pharmaceuticals, Rigel Pharmaceuticals, Inc.

Primary location: South San Francisco United States